Structures of the Carbapenemase OXA-24 in Complex with the β-lactamase Inhibitor Avibactam by Kerff, Frédéric et al.
Structures of the Carbapenemase OXA-24 in Complex with the β-lactamase 
Inhibitor Avibactam  
 
F. Kerff, M. El Ghachi, R. Herman, E. Sauvage, J.-M. Frère, P. Charlier 
University of Liège, Center for Protein Engineering, Liège, Belgium 
Abstract 
 Avibactam is a non-beta-lactam beta-lactamase inhibitor in phase III clinical development that 
is active against class A, C and some class D enzymes. Its spectrum of activity is wider than the 
beta-lactamase inhibitors tazobactam, sulbactam and clavulanic acid. About 400 class D beta-
lactamases have been identified so far. These display a great variety of sequence and substrate 
specificity including carbapenemase activity for enzymes such as OXA-24/40 and -48 which are 
respectively expressed by clinically important A. baumannii and K. pneumoniae strains. The 
efficacy of avibactam on class D beta-lactamases shows large fluctuations that cannot yet be 
explained partly due to the lack of structural data. 
 In this study, we measured the inhibition of the carbapenemase OXA-24 and the 
cephalosporinase OXA-163 by avibactam, showing a significantly higher susceptibility for the 
latter. In addition, we determined the structure of the OXA-24:avibactam complex by x-ray 
crystallography at a 3.1A resolution. The ring-opened avibactam molecule is covalently bound to 
the active Ser81 and the first motif Lys84 is partially carboxylated. The conformation of the 
inhibitor is similar to the one observed in the class A and C beta-lactamases complexes. The main 
difference is the absence of a hydrogen bond with the asparagine of the second conserved motif 
which is replaced by a valine in class D enzymes. The bond between the sulfate part of avibactam 
and the rest of the molecule seems to be cleaved as proposed by Ehmann et al. but stays bound 
to Arg261 and to Lys218 and Ser219 from the third conserved motif. 
 From the available data, the lower susceptibility of OXA-24 to avibactam compared to OXA-
48 and -163 could not be attributed to a single structural feature. Several factors are therefore 
likely responsible 





Protein expression, purification and crystallization.  The OXA-24 β-lactamase and the R39 DD-peptidase were 
expressed and purified as described previously (1, 2). Crystals were grown at 20 °C by hanging drop vapor diffusion.  
For OXA-24, 2 µl of 10 mg/mL protein solution (20 mM Tris pH8) were mixed with 2 µl of a 1M ammonium sulfate and 
0.1 M bis-tris at pH 6.5 solution. The crystal was soaked for 25 minutes by adding 0.5µL of a 90mM avibactam 
solution. For the R39 DD-peptidase, 2.5 μL of a 25 mg/mL protein solution (also containing 5 mM MgCl2 and 20 mM 
Tris, pH 8) were mixed with 2 μL of well solution (2.5M ammonium sulfate and 0.1 M MES, pH 6) and 0.5 μL of 0.1 M 
CoCl2 solution. Crystals were soaked in a solution consisting of 6 μL of 3M ammonium sulfate and 0.1MMES, pH 6, 
and 0.5 μL of 90mM avibactam for 35 min before data collection. 
Structure determination.  Data were collected on Proxima 1 beamline of the Soleil Synchrotron (Saint Aubin, France). 
Intensities were indexed, integrated and scaled using XDS (3). Refinement and building were carried out using 
REFMAC5 (4) and Coot (5). Data and refinement statistics are summarized in Table 1.  
Enzymatic experiments.  The acylation rates of OXA-24, OXA-163 and the R39 DD-peptidase for avibactam were 
obtained from inactivation experiments using the reporter substrates nitrocefin, ceftazidime and thiolester S2d. 
Comparison of OXA-24:avibactam complex with the 
class A and C β-lactamases and PBP complexes 
 
R39 DD-peptidase (class C PBP) in 
complex with avibactam 
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• The acylation rates of OXA-10 and -24 are similar to that of MtBlaC 
(k2/K = 15 ± 0.5)(10). This can potentially be correlated with the 
absence of an Asn residue binding the avibactam  in the second 
conserved motif. 
• OXA-48 and-163 which only differ by a 4 aa deletion in the loop 
following the 3rd motif  known to be critical for the carbapenemase 
activity (11) have a yet unidentified structural feature that compensates 
for the lower affinity for avibactam due to the absence of a Asn in the 
second conserved motif.  
• As expected from the structures, the loop following the 3rd conserved 
motif in class D β-lactamases is unimportant for avibactam recognition. 
• The R39-avibactam structure is the first structure of avibactam in 
complex with a PBP, showing similarities to the β-lactamase 
complexes. 
• The R39 DD-peptidase has a low affinity for avibactam (similar to  
OXA-10 and OXA-24). despite the interaction with N300 of the 2nd 
conserved motif. 
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Table 1.  Data and refinement statistics 
Enzyme k2/K (M
-1 s-1) 
OXA-24 55 ± 5 
OXA-163 1720 ± 75 
R39- DD-peptidase 27 ± 1 
OXA-10 * 11 ± 1 
OXA-48 * 1400 ± 100 
OXA-24 R39 
           Data Collection 
Space group P412121 P1 21 1 
a, b, c (Å) 103.18, 103.18, 87.69 103.67, 92.08, 107.16 
α, β, γ (°) 90, 90, 90 90, 94.36, 90 
Resolution range (Å) 46.1-3.10 (3.27 - 3.10) 46.2-2.2 (2.32-2.2 ) 
No. of unique reflections 9014 (1278) 99905 (14438) 
Rmerge (%) 22.2 (83.1) 6.3 (49.6) 
Rpim (%) 6 (22.5) 3.7 (28.7) 
<I>/<σI>  11.2 (5,4) 12.8 (2.7) 
Completeness (%) 100 (100) 98.1 (97,9) 
Redundancy  14.1 (14,3) 3.8 (3,9) 
             Refinement 
Resolution range (Å) 46.1-3.10 (3.18 – 3.1) 46.2-2.2 (2.26-2.2) 
R work (%) 19,22 (24.9) 18,07 (23.8) 
R free (%) 22,95 (36.3) 22,59 (27.2) 
No. of non hydrogen atoms 1969  14306 
Number of water molecules 12 655 
Mean B factor (all atoms) (Å2) 39.2 41.5 
RMS deviations from ideal stereochemistry: 
   Bond lengths (Å) 0,0099 0,0103 
   Bond angles (o) 1,22 1,19 
Ramachandran plot: 
   Favoured region (%)   95,8 96,8 
   Allowed regions (%) 4.2 3 
   Outlier regions (%) 0 0,2 
Figure 1. Structure at a 3.1Å resolution of the 
avibactam molecule covalently bound to the active 
Ser 81 of OXA-24. The corresponding 2Fo-Fc 
electron density map  is shown at a 1σ level and 
dashed lines denote hydrogen bonds between 
avibactam and the protein. The first motif Lys84 is 
only  partially carboxylated (approximately 50%). 
The bond between the sulfate part of avibactam and 
the rest of the molecule seems to be cleaved as 
proposed by Ehmann et al. (6) but stays bound to 
Arg261 and to Lys218 and Ser219 from the third 
conserved motif 
This structure is similar to the one presented at the 
2011 ECCMID conference by Docquier et al. (7). 
 
Figure 2. Crystals of the R39 DD-peptidase contain 
4 molecules in the asymmetric unit (8). In each of 
them the catalytic S49 is partially acylated by 
avibactam (about 70% occupancy, only monomer A 
is represented). The corresponding 2Fo-Fc electron 
density map  is shown at a 1σ level and dashed lines 
denote hydrogen bonds between avibactam and the 
protein. The sulfate moiety interacts  with T411 and 
T413 of the 3rd conserved motif and no breakage is 
observed with the rest of the compound which 
interacts with the 2nd conserved motif N300. 
This is the first structure of a complex between 
avibactam and a PBP. 
 
* Values taken from Ehmann et al. 
(6) for comparison 
Figure 3. Superposition of the OXA-24:avibactam (grey sticks and ribbons for 
the protein, black lines for avibactam and red dashed lines for hydrogen 
bonds) with the available avibactam complexes : A, the class A β-lactamase 
CTX-M15 (magenta, and black dashed lines for H-bonds) (9), B, the class A β-
lactamase BlaC from Mycobacterium tuberculosis (green) (10), C, the class C 
β-lactamase AmpC from Pseudomonas aeruginosa (cyan) (9) and D, the class 
C PBP R39 DD-peptidase (orange). The avibactam molecules are found in 
very similar orientations in all cases but H-bonds networks slightly differ.  
• Despite the presence of an Arg residue covering the 3rd conserved motif in 
class A and D β-lactamase complexes, only R261 of OXA-24 interacts with 
avibactam. 
• OXA-24 is similar to MtBlaC in its absence of interaction with the 2nd 
conserved motif 
avibactam 
